Keywords: topotarget, totect, cleared, fda, danish, drug, developer

TopoTarget's Totect cleared by FDA

Article | 17 September 2007

Print This

Danish drug developer TopoTarget AS says that its Totect (dexrazone), an agent for the treatment of extravasation resulting from intravenous ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in